Does Routine Submucosal Injection Improve Complete Resection of 4-20 mm Neoplastic Colorectal Polyps?

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM) (Other)
Overall Status
Recruiting
CT.gov ID
NCT04548947
Collaborator
(none)
435
1
1
17.6
24.7

Study Details

Study Description

Brief Summary

This is a prospective, multi-endoscopist, single center, clinical study at tertiary referral center that addresses an important current challenge in the prevention of colorectal cancer (CRC), namely, how to improve the complete removal of CRC precursors. This study will observe the potential benefit of specific polypectomy technique in conjunction with a systematic submucosal injection prior to the polyp resection. This study will evaluate the completeness and incompleteness of the resection of colorectal neoplastic polyps during the procedures.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cold snare polypectomy in conjunction with a submucosal injection
N/A

Detailed Description

Non-detection and incomplete resection of neoplastic colorectal polyps have been identified as the main risk factors for the development of CRC in patients after a colonoscopy. Between 7% and 9% of all newly diagnosed CRCs are estimated to be such "interval cancers," occurring after a previous colonoscopy and before the next surveillance examination. The vast majority of interval cancers are caused by incomplete detection or resection during colonoscopy examination. The contribution of incomplete resection towards interval cancer has recently been pointed out by a panel of experts as one of the cornerstones of CRC prevention that need to be addressed in future research studies. The primary aim of this study is to examine the incomplete adenoma resection rates when performing a cold snare polypectomy in conjunction with a submucosal injection for endoscopic resection of 4-20 mm non-pedunculated colorectal polyps. The subjects are patients, men and women, aged between 45-80 years old that are scheduled for a colonoscopy. The secondary aims are to identify procedure-related complication rates and patient-, polyp-, and endoscopist-related factors associated with incomplete adenoma resection.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
435 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
prospective, multi-endoscopist, single center, clinical study at tertiary referral center (CHUM)prospective, multi-endoscopist, single center, clinical study at tertiary referral center (CHUM)
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Does Routine Submucosal Injection Improve Complete Resection of 4-20 mm Neoplastic Colorectal Polyps?
Actual Study Start Date :
Jan 12, 2021
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Jul 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cold snare polypectomy with a submucosal injection

The procedure will include a cold snare polypectomy with a submucosal injection done prior to the resection.

Procedure: Cold snare polypectomy in conjunction with a submucosal injection
The cold snare polypectomy in conjunction with a submucosal injection is a procedure during which the endoscopist resects the colorectal polyps during a colonoscopy, without any electrocautery.

Outcome Measures

Primary Outcome Measures

  1. Incomplete resection rate (IRR) [Day 1]

    The number of incomplete polyps resected after polypectomy, as defined by any neoplastic tissue found in marginal biopsies.

Secondary Outcome Measures

  1. Immediate bleeding complications [Day 1]

    bleeding requiring endoscopic intervention either during colonoscopy/polypectomy, or requiring an immediate second intervention such as surgery and/or hospital admission

  2. Delayed bleeding complications [14 days after the initial procedure]

    bleeding after the end of the initial procedure 14 days later

  3. Other severe complications [14 days after the initial procedure]

    Post-polypectomy syndrome and perforation requiring endoscopic intervention and/or surgery, and/or hospital admission

  4. Proportion of polyps considered interpretable for complete polyp removal [14 days after the initial procedure]

    Proportion of polyps considered interpretable for complete polyp removal

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Signed consent form; aged 45-80 years old, indication to undergo a colonoscopy
Exclusion Criteria:
  • Known inflammatory bowel disease; active colitis; coagulopathy; familial polyposis syndrome; poor general health, defined as an American Society of Anesthesiologists (ASA) physical status class >3; emergency colonoscopies, hospitalized patients or patients referred from the emergency room.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Universitaire de Montréal Montréal Quebec Canada

Sponsors and Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier:
NCT04548947
Other Study ID Numbers:
  • 20.111
First Posted:
Sep 16, 2020
Last Update Posted:
Feb 4, 2022
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre hospitalier de l'Université de Montréal (CHUM)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 4, 2022